argenx SE | ARGX - Selling And Administration Expenses

Stock Price
710.60
Daily Change
-3.00 -0.42%
Monthly
3.95%
Yearly
12.54%
Q1 Forecast
686.63

argenx SE reported $336.29M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 148M 4.86B Sep/2025
Galapagos EUR 34.55M 3.88M Sep/2025
Genmab DKK 144M 18M Jun/2025
GlaxoSmithKline GBP 2.16B 19M Sep/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Qiagen NV USD 143.11M 5.64M Sep/2025
UCB EUR 1.29B 221M Dec/2024